Abstract
Subacute bacterial endocarditis has been, until recently, an almost uniformly fatal disease. Statistics relative to the mortality in the prepenicillin era have varied from practically 100 per cent as quoted by most observers 1 to 97 per cent noted by Libman. 2 Because of this poor prognosis, the major effort in the past has been directed toward obtaining more effective forms of therapy for the eradication of the infection. Until recently relatively little attention could be devoted to the long-term influence of the infectious process on the myocardium, valvular apparatus and previous cardiovascular abnormalities, because so few patients survived the active phase of the disease. With the advent of more successful therapy, a cure of the active infection has been achieved in a significant number of cases, and greater therapeutic success can be anticipated as the methods improve. Unfortunately, in the entity of healed subacute bacterial endocarditis increasing examples of
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
